REAL-WORLD CLINICAL EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND USTEKINUMAB IN BIOLOGIC-NAIVE PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE EVOLVE EXPANSION STUDY

被引：0
|
作者：
Ferrante, Marc
Christensen, Britt
Bressler, Brian
Brett, Neil R.
Bassel, Marielle
Kamble, Pravin
Adsul, Shashi
Gianchetti, Lauren
Scharl, Michael M.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
16
引用
收藏
页码：S5 / S5
页数：1
相关论文
共 50 条
  • [1] Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with Crohn's disease: Results from the EVOLVE Expansion study
    Ferrante, M.
    Christensen, B.
    Bressler, B.
    Brett, N.
    Bassel, M.
    Kamble, P.
    Adsul, S.
    Gianchetti, L.
    Scharl, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 768 - 769
  • [2] Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with Crohn's disease: Results from the EVOLVE Expansion study
    Ferrante, M.
    Christensen, B.
    Bressler, B.
    Brett, N.
    Bassel, M.
    Kamble, P.
    Adsul, S.
    Gianchetti, L.
    Scharl, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 116 - 117
  • [3] REAL-WORLD CLINICAL EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND USTEKINUMAB IN BIOLOGIC-NAIVE PATIENTS WITH CROHN'S DISEASE BY DISEASE LOCATION: RESULTS FROM THE EVOLVE EXPANSION STUDY
    Scharl, Michael M.
    Christensen, Britt
    Bressler, Brian
    Brett, Neil R.
    Gianchetti, Lauren
    Kamble, Pravin
    Adsul, Shashi
    Farhat, Zeinab
    Ferrante, Marc
    GASTROENTEROLOGY, 2024, 166 (05) : S1422 - S1422
  • [4] Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with Crohn's disease by disease location: Results from the EVOLVE Expansion study
    Scharl, M.
    Christensen, B.
    Bressler, B.
    Brett, N. R.
    Gianchetti, L.
    Kamble, P.
    Adsul, S.
    Farhat, Z.
    Ferrante, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1194 - I1195
  • [5] Real World Clinical Effectiveness and Safety of Vedolizumab and Adalimumab in Biologic-Naive Patients With Crohn's Disease: Results From the EVOLVE Study
    Yarur, Andres
    Bressler, Brian
    Brett, Neil
    Bassel, Marielle
    Adsul, Shashi
    Kamble, Pravin
    Mantzaris, Gerassimos J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S627 - S628
  • [6] Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn's disease patients: results from the EVOLVE study
    Bressler, B.
    Mantzaris, G.
    Silverberg, M.
    Zezos, P.
    Stein, D.
    Colby, C.
    Lissoos, T.
    Lopez, C.
    Natsios, A.
    Radulescu, G.
    Patel, H.
    Demuth, D.
    Yarur, A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S427 - S428
  • [7] REAL-WORLD EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND ANTI-TNF IN BIOLOGIC-NAIVE CROHN'S DISEASE PATIENTS: RESULTS FROM THE EVOLVE STUDY
    Mantzaris, Gerassimos J.
    Yarur, Andres J.
    Silverberg, Mark S.
    Zezos, Petros
    Stein, Dara
    Kim, Hankyul
    Lissoos, Trevor
    Lopez, Claudia
    Natsios, Athanasios
    Radulescu, Gabriela
    Patel, Haridarshan
    Demuth, Dirk
    Bressler, Brian
    GASTROENTEROLOGY, 2019, 156 (06) : S638 - S638
  • [8] Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Bio-naive Patients With Late Crohn's Disease: Results from the EVOLVE Expansion Study
    Christensen, Britt
    Scharl, Michael
    Bressler, Brian
    Halchenko, Yuliya
    Gianchetti, Lauren
    Kamble, Pravin
    Adsul, Shashi
    Farhat, Zeinab
    Ferrante, Marc
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S638 - S639
  • [9] Effectiveness and safety of vedolizumab and infliximab in biologic-naive patients with Crohn's disease: results from the EVOLVE study
    Mantzaris, Gerassimos J.
    Bressler, Brian
    Adsul, Shashi
    Luo, Michelle
    Colby, Chris
    Brett, Neil R.
    Saha, Sumit
    Kamble, Pravin
    Wang, Song
    Yarur, Andres
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (03) : 281 - 291
  • [10] Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Bio-Naive Patients With Non-Complicated Crohn's Disease: Results From the EVOLVE Expansion Study
    Ferrante, Marc
    Christensen, Britt
    Bressler, Brian
    Brett, Neil R.
    Gianchetti, Lauren
    Kamble, Pravin
    Adsul, Shashi
    Farhat, Zeinab
    Scharl, Michael
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S855 - S856
12345